INT302316

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.51
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 4
Total Number 4
Disease Relevance 1.36
Pain Relevance 0.05

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (SOST) extracellular region (SOST) transcription factor binding (SOST)
Anatomy Link Frequency
osteocyte 2
parathyroid 2
SOST (Homo sapiens)
Pain Link Frequency Relevance Heat
antagonist 1 99.36 Very High Very High Very High
transdermal 22 34.88 Quite Low
cva 11 5.00 Very Low Very Low Very Low
carpal tunnel syndrome 3 5.00 Very Low Very Low Very Low
Sciatica 3 5.00 Very Low Very Low Very Low
spinal stenosis 3 5.00 Very Low Very Low Very Low
Potency 3 5.00 Very Low Very Low Very Low
withdrawal 2 5.00 Very Low Very Low Very Low
Bioavailability 2 5.00 Very Low Very Low Very Low
tolerance 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Osteoporosis 128 99.20 Very High Very High Very High
Disease 7 98.32 Very High Very High Very High
Apoptosis 2 89.08 High High
Postmenopausal Osteoporosis 16 86.56 High High
Hematoma 3 54.88 Quite High
Pressure And Volume Under Development 6 54.32 Quite High
Hypercalcemia 40 53.92 Quite High
Dysphagia 3 42.12 Quite Low
Osteolysis 3 36.44 Quite Low
Targeted Disruption 6 34.64 Quite Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
A deletion downstream of the SOST gene, which results in reduced sclerostin expression, is associated with a milder form of the disease called van Buchem disease [5].
Negative_regulation (reduced) of Gene_expression (expression) of sclerostin associated with disease
1) Confidence 0.51 Published 2010 Journal Curr Osteoporos Rep Section Body Doc Link PMC2841260 Disease Relevance 0.20 Pain Relevance 0
Several studies have reported that sclerostin gene expression and protein levels are reduced in animals treated with daily injections of human parathyroid hormone (hPTH) (1–34) [9].
Negative_regulation (reduced) of Gene_expression (expression) of sclerostin gene in parathyroid
2) Confidence 0.51 Published 2010 Journal Curr Osteoporos Rep Section Body Doc Link PMC2841260 Disease Relevance 0.10 Pain Relevance 0
The molecular mechanisms underlying these anabolic effects are still poorly understood, but appear to include both direct actions on osteoblastic cells as well as indirect effects such as through stimulation of IGF-1 production and downregulation of sclerostin, a physiologic antagonist of the important anabolic Wnt-?
Negative_regulation (downregulation) of Gene_expression (production) of sclerostin associated with antagonist and osteoporosis
3) Confidence 0.41 Published 2010 Journal Osteoporos Int Section Body Doc Link PMC2931762 Disease Relevance 0.61 Pain Relevance 0.05
PTH increases bone formation through several actions, including increasing commitment of mesenchymal stem cells to the osteoblast lineage, increasing osteoblast maturation and possibly life span, and reducing the osteocyte production of sclerostin to further stimulate bone formation.
Negative_regulation (reducing) of Gene_expression (production) of sclerostin in osteocyte associated with osteoporosis
4) Confidence 0.32 Published 2010 Journal Curr Osteoporos Rep Section Body Doc Link PMC2841260 Disease Relevance 0.45 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox